Price T Rowe Associates Inc. MD Raises Stock Holdings in Trevi Therapeutics, Inc. (NASDAQ:TRVI)
Price T Rowe Associates Inc. MD increased its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) by 32.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 25,166 shares of the company’s stock after acquiring an additional 6,119 shares during the period. […]
Price T Rowe Associates Inc. MD increased its holdings in shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI – Free Report) by 32.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 25,166 shares of the company’s stock after acquiring an additional 6,119 shares during the period. […]
